bioRxiv · 10.1101/861369
Rapamycin rejuvenates oral health in aging mice
Abstract
Periodontal disease is an age-associated disorder clinically defined by periodontal bone loss, inflammation of the specialized tissues that surround and support the tooth, and microbiome dysbiosis. Currently, there is no therapy for reversing periodontal disease, and treatment is generally restricted to preventive measures or tooth extraction. The FDA-approved drug rapamycin slows aging and extends lifespan in multiple organisms, including mice. Here we demonstrate that short-term treatment with rapamycin rejuvenates the aged oral cavity of elderly mice, including regeneration of periodontal bone, attenuation of gingival and periodontal bone inflammation, and revertive shift of the oral microbiome toward a more youthful composition. This provides a geroscience strategy to potentially rejuvenate oral health and reverse periodontal disease in the elderly. Single Sentence SummaryShort-term treatment with rapamycin reverses periodontal bone loss, attenuates inflammation, and remodels the oral microbiome toward a more youthful state.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
An, J. Y., Kerns, K. A., Ouellette, A., Robinson, L., Morris, D., Kaczorowski, C., Park, S.-I., Mekvanich, T., Kang, A., McLean, J. S., Cox, T., Kaeberlein, M.. 2019-12-10. Rapamycin rejuvenates oral health in aging mice. https://doi.org/10.1101/861369
Cite the original work for its findings. Save a collection to share your selection of sources.